CD2AP

CD2 associated protein

Basic information

Region (hg38): 6:47477789-47627263

Links

ENSG00000198087NCBI:23607OMIM:604241HGNC:14258Uniprot:Q9Y5K6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • focal segmental glomerulosclerosis 3, susceptibility to (Limited), mode of inheritance: AR
  • familial idiopathic steroid-resistant nephrotic syndrome (Supportive), mode of inheritance: AD
  • focal segmental glomerulosclerosis 3, susceptibility to (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Focal segmental glomerulosclerosis 3ARRenalThe condition can involve renal failure, and early diagnosis may enable management considerations; Renal transplant has been describedRenal17713465

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CD2AP gene.

  • Focal segmental glomerulosclerosis 3, susceptibility to (3 variants)
  • Focal segmental glomerulosclerosis 3 (1 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD2AP gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
31
clinvar
1
clinvar
35
missense
100
clinvar
12
clinvar
112
nonsense
1
clinvar
1
clinvar
1
clinvar
3
start loss
0
frameshift
2
clinvar
2
clinvar
2
clinvar
6
inframe indel
2
clinvar
1
clinvar
3
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
5
13
18
non coding
66
clinvar
44
clinvar
57
clinvar
167
Total 4 4 174 88 58

Highest pathogenic variant AF is 0.0000264

Variants in CD2AP

This is a list of pathogenic ClinVar variants found in the CD2AP region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-47477804-C-A Focal segmental glomerulosclerosis 3, susceptibility to Benign/Likely benign (Jan 16, 2020)357149
6-47477804-C-G Focal segmental glomerulosclerosis 3, susceptibility to Benign (Nov 11, 2018)357150
6-47477807-C-T Focal segmental glomerulosclerosis 3, susceptibility to Uncertain significance (Jan 12, 2018)357151
6-47477916-C-T Focal segmental glomerulosclerosis 3, susceptibility to Uncertain significance (Jan 12, 2018)357152
6-47477921-G-C Focal segmental glomerulosclerosis 3, susceptibility to Uncertain significance (Jan 13, 2018)357153
6-47477948-G-C Focal segmental glomerulosclerosis 3, susceptibility to Benign (Jan 13, 2018)357154
6-47477978-G-A Focal segmental glomerulosclerosis 3, susceptibility to Benign (Jan 13, 2018)357155
6-47478048-C-T Focal segmental glomerulosclerosis 3, susceptibility to Uncertain significance (Jan 13, 2018)357156
6-47478053-A-C Focal segmental glomerulosclerosis 3, susceptibility to Benign (Nov 10, 2018)357157
6-47478054-G-A Focal segmental glomerulosclerosis 3, susceptibility to Uncertain significance (Jan 13, 2018)357158
6-47478075-TAGG-T Focal segmental glomerulosclerosis Likely benign (Jun 14, 2016)357159
6-47478079-A-G Focal segmental glomerulosclerosis 3, susceptibility to Uncertain significance (Apr 27, 2017)910328
6-47478115-C-G Focal segmental glomerulosclerosis 3, susceptibility to Uncertain significance (Jan 13, 2018)357160
6-47478176-C-A Focal segmental glomerulosclerosis 3, susceptibility to Uncertain significance (Jan 13, 2018)910329
6-47478191-T-A Focal segmental glomerulosclerosis 3, susceptibility to • not specified Benign (Jul 15, 2024)357162
6-47478190-C-CAGG Focal segmental glomerulosclerosis Likely benign (Jun 14, 2016)357161
6-47478236-G-GC Focal segmental glomerulosclerosis Uncertain significance (Jun 14, 2016)357163
6-47478251-AAG-A Likely benign (Aug 09, 2022)1987219
6-47478257-C-G Likely benign (Nov 27, 2020)1564026
6-47478264-G-A not specified Benign/Likely benign (Jan 02, 2024)260190
6-47478510-T-G Benign (Nov 10, 2018)1273719
6-47503260-G-A Focal segmental glomerulosclerosis 3, susceptibility to Likely benign (Jun 27, 2023)1638570
6-47503280-T-G Uncertain significance (May 06, 2023)2969694
6-47503284-C-G CD2AP-related disorder Uncertain significance (Oct 11, 2023)2633918
6-47503298-A-G Inborn genetic diseases Uncertain significance (Oct 16, 2023)3140498

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CD2APprotein_codingprotein_codingENST00000359314 18149475
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2300.7701257080401257480.000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.002153233231.000.00001554158
Missense in Polyphen6382.350.765021105
Synonymous-0.6071221141.070.000005511212
Loss of Function4.36938.00.2370.00000202483

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004460.000445
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.0001670.000167
Middle Eastern0.0001090.000109
South Asian0.0001960.000196
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton (PubMed:10339567). In collaboration with CBLC, modulates the rate of RET turnover and may act as regulatory checkpoint that limits the potency of GDNF on neuronal survival. Controls CBLC function, converting it from an inhibitor to a promoter of RET degradation (By similarity). May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell (By similarity). May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis (PubMed:15800069). Plays a role in epithelial cell junctions formation (PubMed:22891260). {ECO:0000250|UniProtKB:F1LRS8, ECO:0000250|UniProtKB:Q9JLQ0, ECO:0000269|PubMed:10339567, ECO:0000269|PubMed:15800069, ECO:0000269|PubMed:22891260}.;
Disease
DISEASE: Focal segmental glomerulosclerosis 3 (FSGS3) [MIM:607832]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:12764198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Bacterial invasion of epithelial cells - Homo sapiens (human);Primary Focal Segmental Glomerulosclerosis FSGS;TCR;Nephrin family interactions;Cell-Cell communication;Nephrin/Neph1 signaling in the kidney podocyte;VEGFR1 specific signals (Consensus)

Recessive Scores

pRec
0.379

Intolerance Scores

loftool
0.696
rvis_EVS
-0.35
rvis_percentile_EVS
29.43

Haploinsufficiency Scores

pHI
0.695
hipred
Y
hipred_score
0.708
ghis
0.656

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.894

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cd2ap
Phenotype
homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; immune system phenotype; renal/urinary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
cd2ap
Affected structure
podocyte
Phenotype tag
abnormal
Phenotype quality
structure

Gene ontology

Biological process
substrate-dependent cell migration, cell extension;actin filament organization;cell cycle;signal transduction;vesicle organization;negative regulation of transforming growth factor beta1 production;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of receptor-mediated endocytosis;negative regulation of small GTPase mediated signal transduction;cell division;protein-containing complex assembly;cell-cell adhesion;positive regulation of protein localization to nucleus;regulation of actin cytoskeleton reorganization
Cellular component
ruffle;cytoplasm;plasma membrane;cell-cell junction;actin cytoskeleton;endocytic vesicle;filamentous actin;perinuclear region of cytoplasm;extracellular exosome
Molecular function
vascular endothelial growth factor receptor binding;structural constituent of cytoskeleton;protein binding;beta-catenin binding;protein C-terminus binding;SH3 domain binding;protein-containing complex binding;cadherin binding